1. Home
  2. INSE vs GNFT Comparison

INSE vs GNFT Comparison

Compare INSE & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSE
  • GNFT
  • Stock Information
  • Founded
  • INSE 2002
  • GNFT 1999
  • Country
  • INSE United States
  • GNFT France
  • Employees
  • INSE N/A
  • GNFT N/A
  • Industry
  • INSE Computer Software: Prepackaged Software
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INSE Technology
  • GNFT Health Care
  • Exchange
  • INSE Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • INSE 222.8M
  • GNFT 214.5M
  • IPO Year
  • INSE N/A
  • GNFT 2019
  • Fundamental
  • Price
  • INSE $8.55
  • GNFT $3.89
  • Analyst Decision
  • INSE Buy
  • GNFT Strong Buy
  • Analyst Count
  • INSE 5
  • GNFT 1
  • Target Price
  • INSE $12.20
  • GNFT $13.00
  • AVG Volume (30 Days)
  • INSE 175.6K
  • GNFT 4.2K
  • Earning Date
  • INSE 08-07-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • INSE N/A
  • GNFT N/A
  • EPS Growth
  • INSE 3507.71
  • GNFT N/A
  • EPS
  • INSE 2.43
  • GNFT 0.03
  • Revenue
  • INSE $295,200,000.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • INSE $3.05
  • GNFT $15.98
  • Revenue Next Year
  • INSE $1.22
  • GNFT N/A
  • P/E Ratio
  • INSE $3.46
  • GNFT $125.30
  • Revenue Growth
  • INSE N/A
  • GNFT 105.01
  • 52 Week Low
  • INSE $6.51
  • GNFT $2.55
  • 52 Week High
  • INSE $11.61
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • INSE 65.57
  • GNFT 47.15
  • Support Level
  • INSE $7.30
  • GNFT $3.61
  • Resistance Level
  • INSE $8.58
  • GNFT $3.95
  • Average True Range (ATR)
  • INSE 0.36
  • GNFT 0.16
  • MACD
  • INSE 0.10
  • GNFT -0.03
  • Stochastic Oscillator
  • INSE 97.67
  • GNFT 44.87

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: